Perspectives on Enquiry & Evidence

Cytel has grown significantly over the last 30 years, with operations across North America, Europe, and India. All of..

A solid and robust QC process is one vital component of ensuring quality programming delivery. Angelo Tinazzi and..

Imagine that it’s been three years since the completion of a trial, and that suddenly a regulatory body calls into..

As more clinical trials make use of adaptive designs, investors have come to realize that high quality trial designs..

During an invited speakers session at the lnternational Society for Clinical Biostatistics, Cytel VP Yannis Jemiai was..

Beyond Wild Horses: Developing Innovation at Cytel "Horse-and-pony" by arjecahn on flickr...

A recent Cytel Seminar on Adaptive Statistical Designs featured a talk by Michael Elashoff (Patient Profiles) on..

This is the first of a three part post in which we will consider (i) improvements to trial quality that result from..